Parabilis Medicines is rated a Buy; it leverages rare, genetically simple tumors to validate its Helicon platform. Read more ...
Single B-cell technologies have emerged as powerful screening tools to accelerate antibody discovery, offering R&D teams the potential to interrogate millions of individual antibody-secreting cells to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results